SOŠKA, Vladimír, Jindřich FIALA, Kateřina NEBESKÁ, Jiří JARKOVSKÝ and Drahoslava HRUBÁ. The atherogenic index of plasma is increased by hormonal contraception. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. NORWAY: TAYLOR & FRANCIS AS, 2011, vol. 71, No 2, p. 94-100. ISSN 0036-5513. doi:10.3109/00365513.2011.553240.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The atherogenic index of plasma is increased by hormonal contraception
Authors SOŠKA, Vladimír (203 Czech Republic, guarantor, belonging to the institution), Jindřich FIALA (203 Czech Republic, belonging to the institution), Kateřina NEBESKÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Drahoslava HRUBÁ (203 Czech Republic, belonging to the institution).
Edition SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, NORWAY, TAYLOR & FRANCIS AS, 2011, 0036-5513.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.156
RIV identification code RIV/00216224:14110/11:00056966
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3109/00365513.2011.553240
UT WoS 000288126400004
Keywords in English Oral contraceptives; dyslipidemias; cardiovascular diseases; risk factors; HDL cholesterol; triglycerides; C-reactive protein
Tags International impact
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 12/4/2012 09:40.
Abstract
The aim of this study was to determine if hormonal contraceptives affect the new atherogenic index of plasma (AIP) = log[triglycerides (TG)/high-density lipoprotein cholesterol (HDL-C)] together with the total cholesterol/HDL-C (TC/HDL-C) and the apolipoprotein B/apolipoprotein A1 (apoB/apoA1) ratios. The increased AIP and hs-CRP concentration after 9 months of hormonal contraception demonstrate that contraceptive-induced dyslipidemia has a proatherogenic nature, even when the TC/HDL-C and the apoB/apoA1 ratios are unchanged.
Links
NR8841, research and development projectName: Hodnocení účinků různých typů hormonálních kontraceptiv na biochemické ukazatele kardiovaskulárního rizika žen s rozdílným kuřáckým a výživovým chováním a možnosti jejich ovlivnění
Investor: Ministry of Health of the CR, Ministry of Agriculture R&D Programme
PrintDisplayed: 27/9/2021 06:24